Results 171 to 180 of about 7,789 (204)

JAK-1 inhibitors in the management of atopic dermatitis in patients over 65 years old: a descriptive cohort study. [PDF]

Sci Rep
Zheng J, Robles-Velasco K, Sharma S, de Souza Lima ICA, Pasquini VF, Ducati RG, Lima H.   +6 more
europepmc   +1 more source

Table 1_Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis.docx

Cong Zhang (582922), Zhiwen Fu (689083), Jinmei Liu (1542721), Shijun Li (165293), Xu Chen (432759), Yi Zhang (9093), Jiyi Xie (17127437)   +6 more
openalex   +1 more source

Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease. [PDF]

J Crohns Colitis
Vermeire S, Colombel JF, Danese S, Panaccione R, Peyrin-Biroulet L, Beck K, Chaparro M, Gisbert JP, Dubcenco E, Klaff J, Naling G, Ford S, Remple V, Joshi N, Suravaram S, Duncan B, Wang Y, Wick-Urban B, Loftus EV.   +18 more
europepmc   +1 more source

Oral JΑΚ Inhibitors in Vitiligo Treatment. [PDF]

Dermatol Ther (Heidelb)
Panagopoulou A, Sotiriou E, Papadimitriou I, Pavlidis A, Bakirtzi K, Tsentemeidou A, Arabatzis M, Vakirlis E, Kiritsi D.   +8 more
europepmc   +1 more source

Upadacitinib versus Tofacitinib in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis. [PDF]

Inflamm Intest Dis
Alsaleh T, Mohammed A, Farooq A, Elamin M, Akl A, Yassin KM, Elnaggar A, Seminerio J.   +7 more
europepmc   +1 more source

Erosive Oral Lichen Planus Treated With Upadacitinib Amid Systemic Psoriatic Therapy. [PDF]

Cureus
Ames E, Sanders MS, Cotter D.
europepmc   +1 more source

Melkersson-Rosenthal syndrome and upadacitinib: A case report. [PDF]

JAAD Case Rep
Turpin DB, Grafton LH.
europepmc   +1 more source

Post-marketing surveillance of upadacitinib: multilevel analysis of venous thromboembolism reporting in global data and rheumatoid arthritis. [PDF]

Front Med (Lausanne)
Ferreira-da-Silva R, Lobo M, Abreu AR, Pereira-Macedo J, Mós B, Rodriguez CA, Lourenço IM, Vieira I, Polónia JJ, Gouveia L, Silva L, Morato M, Pinto M, Forrester M, Pereira M, Rodrigues N, Biase T, Ribeiro I.   +17 more
europepmc   +1 more source

Upadacitinib: One More Option in the Treatment ofPatients with Rheumatoid Arthritis and Crohn's Disease

A. Del Giudice, D. Giuggioli, A. Bertani, G. Sandri   +3 more
openalex   +1 more source

Janus Kinase Inhibitor Upadacitinib in Elderly-Onset Rheumatoid Arthritis With Hip Osteoarthritis: A Case Report. [PDF]

Am J Case Rep
Sanji Y, Matsushita I, Takahashi E, Fukui M, Kitajima H, Kaneuji A.   +5 more
europepmc   +1 more source